Company / Return on Assets (ROA)
Traws Pharma, Inc. Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-1568.5%
FY2024
5-year range
-1568.5% / -41.0%
FY2020-FY2024
Trend
-1776.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -1776% YoY in FY2024, a notable deviation from the 9-year average annual change of -217%.
Based on SEC 10-K filings.
-1568.5% in FY2024 with a 5-year CAGR of -1481.6%.
Declined from -41.0% to -1568.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -1523.1pp
- 5-Year Change
- -1481.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 1776.1% year-over-year.
- Peak return on assets (roa) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -1568.5% | -1776.1% |
| FY2023 | -83.6% | -103.7% |
| FY2022 | -41.0% | +9.5% |
| FY2021 | -45.4% | +57.8% |
| FY2020 | -107.6% | -23.8% |
| FY2019 | -86.9% | +35.4% |
| FY2018 | -134.4% | +66.0% |
| FY2017 | -395.0% | -282.7% |
| FY2016 | -103.2% | +62.0% |
| FY2015 | -271.6% | -329.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026